Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2021, Vol. 41 Issue (10): 42-51    DOI: 10.13523/j.cb.2104042
    
Construction of Small Diameter Tissue Engineering Blood Vessels by Coaxial Printing
SONG Biao-biao1,GU Qi1,2,3,**()
1 School of Life Science, Department of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230027, China
2 State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China
3 Beijing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China
Download: HTML   PDF(1925KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Currently, with the severity of population aging, cardiovascular disease(CVD) brings about health problems and unbearable economic burdens. In ischemic illnesses caused by the damage of small-diameter blood vessels, blood vessel transplantation has become an effective solution to tackle this challenge. However, small-diameter blood vessels are currently in high demand. Therefore, it is pretty crucial to construct small-diameter tissue-engineered blood vessels (TEBV) using tissue engineering methods. With the advancement of tissue engineering and 3D printing technology, the research of vascular grafts has developed rapidly. At present, most of the vascular graft materials used for large-diameter vascular grafts are polyester and polytetrafluoroethylene (PTFE). However, it is not applicable for the fabrication of small-diameter TEBV, in which case a myriad of unavoidable problems may come alone, such as inflammation and thrombosis. At the same time, current TEBV has such limitations as insufficient mechanical properties, which seriously hinder the clinical translation of TEBV. Therefore, in this experiment, we independently synthesized methacrylated gelatin (GelMA) and RGD-modified sodium alginate (RGD-Alginate) combined to form a double cross-linking system. By adding xanthan gum, the printability of the system is guaranteed. We used coaxial printing to fabricate a tube-like structure. Hybrid material system was characterized by a low vacuum cryo-scanning electron microscope. We found honeycomb-like forms appear on the surface, indicating that oxygen and nutrients could be provided to the cells in the tube through penetration. As for the selection of materials, the sacrificial material in the inner layer is 25% Pluronic F127 dissolved in 2% calcium chloride (CaCl2), and the outer material is 4% RGD-Alginate+5% GelMA+2% Xanthan Gum. During the printing process, the extrusion pressure of the printer is related to the diameter of the selected coaxial nozzles. When the 18G/14G coaxial nozzle is applied, the printing pressure is 55 kPa, and the printing speed is 5 mm/s. The syringe pump is utilized to extrude the material of the outer layer, whose speed is 264 μL/min. In the printing procedure, we selected two nozzles with different diameters to effectively fabricate a tube matching the nozzle diameter. In addition, a device for detecting burst pressure was established, which uses constant extrusion of the syringe pump to provide stable pressure to the tested tube. It has been demonstrated that the burst pressure is 328 mmHg±14 mmHg, which is quite different from the burst pressure of natural blood vessels in vivo. At the same time, it is sufficient to bear the vascular pressure in the physiological state of the human body. Human umbilical vein endothelial cells (HUVECs) were perfused into the tube-like structure (cell concentration was 1×107/mL). Through the imaging characterization of the cell state in the tube-like structure, it was found that HUVECs can be stably attached to the inner wall of a fabricated tube-like structure.



Key wordsRGD-ALG      Coaxial printing      Tissue engineered blood vessel     
Received: 23 April 2021      Published: 08 November 2021
ZTFLH:  Q819  
Corresponding Authors: Qi GU     E-mail: qgu@ioz.ac.cn
Cite this article:

SONG Biao-biao,GU Qi. Construction of Small Diameter Tissue Engineering Blood Vessels by Coaxial Printing. China Biotechnology, 2021, 41(10): 42-51.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.2104042     OR     https://manu60.magtech.com.cn/biotech/Y2021/V41/I10/42

Fig.1 Synthesis and characterization of materials (a) The synthetic schematic of GelMA (b) The synthetic schematic of RGD-ALG (c) The infrared spectra of RGD-ALG, RGD and ALG (d) Scanning electron microscope imaging under 3 000 magnification, bar=3 μm
Fig.2 The effect of RGD on the attachment of RFP-HUVECs (a) RFP-HUVECs adhesion in the tube prepared by RGD-ALG, bar=100 μm (b) RFP-HUVECs adhesion in the tube prepared by ALG, the arrowheads point to cell state in the tube, bar=100 μm
Fig.3 The rheology test of materials (a) The viscosity of all hydrogels is negatively correlated with the shear rate (b) The modulus of hydrogel changes with the change of shear rate (c) The statistical chart of the printing state (d-f) Physical drawing of extrusion printing, bar=5 mm
Fig.4 Coaxial printing (a) Illustration of coaxial printing (b) Core/shell 3D printing by coaxial printing (c-f) The combinations of various core and shell nozzles fabricate tubes with different inner diameters, (c-d) Bar=500 μm and (e-f) bar=200 μm
Fig.5 Schematic diagram of burst pressure device (a) The fabrication of burst pressure device (b) The burst pressure of saphenous vein and TEBV of different diameters (* P< 0.05, ** P< 0.01, *** P< 0.001, n = 3)
Fig.6 Attachment of HUVECs to the wall of tube RFP-HUVECs can stably attach to the wall of tube, bar=500 μm
[1]   Perk J, de Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Atherosclerosis, 2012, 223(1): 1-68.
doi: 10.1016/j.atherosclerosis.2012.05.007
[2]   Song H H G, Rumma R T, Ozaki C K, et al. Vascular tissue engineering: progress, challenges, and clinical promise. Cell Stem Cell, 2018, 22(3): 340-354.
doi: 10.1016/j.stem.2018.02.009
[3]   Mozaffarian D, Benjamin E J, Go A S, et al. Executive summary: heart disease and stroke statistics-2016 update: a report from the American heart association. Circulation, 2016, 133(4): 447-454.
doi: 10.1161/CIR.0000000000000366 pmid: 26811276
[4]   Kunlin J. Long vein transplantation in treatment of ischemia caused by arteritis. Revue de Chirurgie, 1951, 70(7-8): 206-235.
[5]   Nugent H M, Edelman E R. Tissue engineering therapy for cardiovascular disease. Circulation Research, 2003, 92(10): 1068-1078.
pmid: 12775655
[6]   Hasan A, Memic A, Annabi N, et al. Electrospun scaffolds for tissue engineering of vascular grafts. Acta Biomaterialia, 2014, 10(1): 11-25.
doi: 10.1016/j.actbio.2013.08.022
[7]   Nair L S, Laurencin C T. Biodegradable polymers as biomaterials. Progress in Polymer Science, 2007, 32(8-9): 762-798.
doi: 10.1016/j.progpolymsci.2007.05.017
[8]   Weinberg C B, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science, 1986, 231(4736): 397-400.
pmid: 2934816
[9]   Ayala P, Dai E B, Hawes M, et al. Evaluation of a bioengineered construct for tissue engineering applications. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2018, 106(6): 2345-2354.
doi: 10.1002/jbm.b.v106.6
[10]   Quint C, Arief M, Muto A, et al. Allogeneic human tissue-engineered blood vessel. Journal of Vascular Surgery, 2012, 55(3): 790-798.
doi: 10.1016/j.jvs.2011.07.098 pmid: 22056286
[11]   Lawson J H, Glickman M H, Ilzecki M. Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials. Lancet, 2016, 387(10032): 2026-2034.
doi: 10.1016/S0140-6736(16)00557-2
[12]   L’Heureux N, Dusserre N, Konig G, et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nature Medicine, 2006, 12(3): 361-365.
doi: 10.1038/nm1364
[13]   Galili U. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunology and Cell Biology, 2005, 83(6): 674-686.
pmid: 16266320
[14]   Kim G, Ahn S, Kim Y, et al. Coaxial structured collagen-alginate scaffolds: fabrication, physical properties, and biomedical application for skin tissue regeneration. Journal of Materials Chemistry, 2011, 21(17): 6165-6172.
doi: 10.1039/c0jm03452e
[15]   Kjar A, McFarland B, Mecham K, et al. Engineering of tissue constructs using coaxial bioprinting. Bioactive Materials, 2021, 6(2): 460-471.
doi: 10.1016/j.bioactmat.2020.08.020
[16]   Zeng Z W, Hu C S, Liang Q F, et al. Coaxial-printed small-diameter polyelectrolyte-based tubes with an electrostatic self-assembly of heparin and YIGSR peptide for antithrombogenicity and endothelialization. Bioactive Materials, 2021, 6(6): 1628-1638.
doi: 10.1016/j.bioactmat.2020.10.028
[17]   Liang Q F, Gao F, Zeng Z W, et al. Coaxial scale-up printing of diameter-tunable biohybrid hydrogel microtubes with high strength, perfusability, and endothelialization. Advanced Functional Materials, 2020, 30(43): 2001485.
doi: 10.1002/adfm.v30.43
[18]   Kuo C K, Ma P X. Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: part 1, structure, gelation rate and mechanical properties. Biomaterials, 2001, 22(6): 511-521.
pmid: 11219714
[19]   Fu S, Thacker A, Sperger D M, et al. Relevance of rheological properties of sodium alginate in solution to calcium alginate gel properties. AAPS PharmSciTech, 2011, 12(2): 453-460.
doi: 10.1208/s12249-011-9587-0
[20]   Jørgensen T E, Sletmoen M, Draget K I, et al. Influence of oligoguluronates on alginate gelation, kinetics, and polymer organization. Biomacromolecules, 2007, 8(8): 2388-2397.
pmid: 17602585
[21]   Jia J, Richards D J, Pollard S, et al. Engineering alginate as bioink for bioprinting. Acta Biomaterialia, 2014, 10(10): 4323-4331.
doi: 10.1016/j.actbio.2014.06.034 pmid: 24998183
[22]   Liu Y X, Chan-Park M B. A biomimetic hydrogel based on methacrylated dextran-graft-lysine and gelatin for 3D smooth muscle cell culture. Biomaterials, 2010, 31(6): 1158-1170.
doi: 10.1016/j.biomaterials.2009.10.040
[23]   Van den Steen P E, Dubois B, Nelissen I, et al. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Critical Reviews in Biochemistry and Molecular Biology, 2002, 37(6): 375-536.
doi: 10.1080/10409230290771546
[24]   Bertassoni L E, Cecconi M, Manoharan V, et al. Hydrogel bioprinted microchannel networks for vascularization of tissue engineering constructs. Lab on a Chip, 2014, 14(13): 2202-2211.
doi: 10.1039/c4lc00030g pmid: 24860845
[25]   Nemeth C L, Janebodin K, Yuan A E, et al. Enhanced chondrogenic differentiation of dental pulp stem cells using nanopatterned PEG-GelMA-HA hydrogels. Tissue Engineering Part A, 2014, 20(21-22): 2817-2829.
doi: 10.1089/ten.tea.2013.0614
[26]   de Eke G, de Mangir N, Hasirci N, et al. Development of a UV crosslinked biodegradable hydrogel containing adipose derived stem cells to promote vascularization for skin wounds and tissue engineering. Biomaterials, 2017, 129: 188-198.
doi: 10.1016/j.biomaterials.2017.03.021
[27]   Navaei A, Saini H, Christenson W, et al. Gold nanorod-incorporated gelatin-based conductive hydrogels for engineering cardiac tissue constructs. Acta Biomaterialia, 2016, 41: 133-146.
doi: 10.1016/j.actbio.2016.05.027 pmid: 27212425
[28]   Yue K, Trujillo-de Santiago G, Alvarez M M, et al. Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels. Biomaterials, 2015, 73: 254-271.
doi: 10.1016/j.biomaterials.2015.08.045
[29]   Gao G, Lee J H, Jang J, et al. Tissue engineered bio-blood-vessels constructed using a tissue-specific bioink and 3D coaxial cell printing technique: a novel therapy for ischemic disease. Advanced Functional Materials, 2017, 27(33): 1700798.
doi: 10.1002/adfm.201700798
[30]   Gao G, Park W, Kim B S, et al. Construction of a novel in vitro atherosclerotic model from geometry-tunable artery equivalents engineered via in-bath coaxial cell printing. Advanced Functional Materials, 2021, 31(10): 2008878.
doi: 10.1002/adfm.v31.10
[31]   Konig G, McAllister T N, Dusserre N, et al. Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery. Biomaterials, 2009, 30(8): 1542-1550.
doi: 10.1016/j.biomaterials.2008.11.011
[32]   Galie P A, Nguyen D H T, Choi C K, et al. Fluid shear stress threshold regulates angiogenic sprouting. PNAS, 2014, 111(22): 7968-7973.
doi: 10.1073/pnas.1310842111
[33]   Song J W, Munn L L. Fluid forces control endothelial sprouting. PNAS, 2011, 108(37): 15342-15347.
doi: 10.1073/pnas.1105316108
[1] . [J]. China Biotechnology, 2021, 41(12): 1-3.
[2] WU Han-rong,WANG Ying,HUANG Ying-ming,LI Dong-xue,LI Zhi-fei,FANG Zi-han,FAN Lin. Promote the Innovation and Transformation of Biotechnology by Base Platform[J]. China Biotechnology, 2021, 41(12): 141-147.
[3] YIN Ze-chao,WANG Xiao-fang,LONG Yan,DONG Zhen-ying,WAN Xiang-yuan. Advances on Genetic Research and Mechanism Analysis on Maize Resistance to Ear Rot[J]. China Biotechnology, 2021, 41(12): 103-115.
[4] LENG Yan,SUN Kang-tai,LIU Qian-qian,PU A-qing,LI Xiang,WAN Xiang-yuan,WEI Xun. Trends of Global Gene-edited Crops Supervision[J]. China Biotechnology, 2021, 41(12): 24-29.
[5] HE Wei,ZHU Lei,LIU Xin-ze,AN Xue-li,WAN Xiang-yuan. Research Progress on Maize Genetic Transformation and Commercial Development of Transgenic Maize[J]. China Biotechnology, 2021, 41(12): 13-23.
[6] YANG Meng-bing,JIANG Yi-lin,ZHU Lei,AN Xue-li,WAN Xiang-yuan. CRISPR/Cas Plant Genome Editing Systems and Their Applications in Maize[J]. China Biotechnology, 2021, 41(12): 4-12.
[7] YIN Fang-bing,WANG Cheng,LONG Yan,DONG Zhen-ying,WAN Xiang-yuan. Progress on Dissecting Genetic Architecture and Formation Mechanism of Maize Ear Traits[J]. China Biotechnology, 2021, 41(12): 30-46.
[8] QIN Wen-xuan,LIU Xin,LONG Yan,DONG Zhen-ying,WAN Xiang-yuan. Progress on Genetic Analysis and Molecular Dissection on Maize Leaf Angle Traits[J]. China Biotechnology, 2021, 41(12): 74-87.
[9] WANG Rui-pu,DONG Zhen-ying,GAO Yue-xin,LONG Yan,WAN Xiang-yuan. Research Progress on Genetic Structure and Regulation Mechanism on Starch Content in Maize Kernel[J]. China Biotechnology, 2021, 41(12): 47-60.
[10] MA Ya-jie,GAO Yue-xin,LI Yi-ping,LONG Yan,DONG Zhen-ying,WAN Xiang-yuan. Progress on Genetic Analysis and Molecular Dissection on Maize Plant Height and Ear Height[J]. China Biotechnology, 2021, 41(12): 61-73.
[11] WANG Yan-bo,WEI Jia,LONG Yan,DONG Zhen-ying,WAN Xiang-yuan. Research Advances on Genetic Structure and Molecular Mechanism Underlying the Formation of Tassel Traits in Maize[J]. China Biotechnology, 2021, 41(12): 88-102.
[12] MAO Kai-yun,LI Rong,LI Dan-dan,ZHAO Ruo-chun,FAN Yue-lei,JIANG Hong-bo. Analysis of the Current Status of Global Bispecific Antibody Development[J]. China Biotechnology, 2021, 41(11): 110-118.
[13] WU Han-rong,WANG Ying,YANG Li,GE Yao,FAN Ling. Current Situation and Development Suggestions of China’s Biotechnology Base Platform[J]. China Biotechnology, 2021, 41(11): 119-123.
[14] LIU Tian-yi,FENG Hui,SALSABEEL Yousuf,XIE Ling-li,MIAO Xiang-yang. Research Progress of lncRNA in Animal Fat Deposition[J]. China Biotechnology, 2021, 41(11): 82-88.
[15] XUE Zhi-yong,DAI Hong-sheng,ZHANG Xian-yuan,SUN Yan-ying,HUANG Zhi-wei. Effects of Vitreoscilla Hemoglobin Gene on Growth and Intracellular Oxidation State of Saccharomyces cerevisiae[J]. China Biotechnology, 2021, 41(11): 32-39.